Instil Bio, Inc. (TIL) stock
TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.24−0.07 (-1.11%)
Close on Nov 12, 2026Market cap $42.32MP/E –Yield –
Instil Bio operating margin
Operating margin is operating income as a percentage of revenue.
Instil Bio's operating margin for the twelve months ending Jun 30, 2021 was -161484.6%. For fiscal 2020 it was -24379.7%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -24379.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | -14828.8% | – |
| Q2 FY2020 | Jun 30, 2020 | -10935.7% | – |
| Q1 FY2020 | Mar 31, 2020 | -8779.5% | – |
See a number that looks wrong?